

EPA moves to pull rat poison from shelves
The Obama administration claims a company that makes rat poison is refusing to comply with standards to protect children, and is moving to ban 12 of its products from the market.
The Environmental Protection Agency said Reckitt Benckiser Inc. is the only manufacturer of rat poisons that has refused to work with the government on new safety standards. The company’s product brands include Veet, Air Wick and Clearasil.
“Moving forward to ban these products will prevent completely avoidable risks to children,” said James Jones, acting assistant administrator for EPA’s Office of Chemical Safety and Pollution Prevention in a statement. “With this action, EPA is ensuring that the products on the market are both safe and effective for consumers.”
Reckitt Benckiser can appeal the decision within 30 days, according to Businessweek. If that process does not move forward, the EPA can continue with imposing the ban. A spokesman for Reckitt Benckiser denied comment to the magazine.
The agency requires consumer poison products to be inside “protective tamper-resistant bait stations," with pellets or other materials that cannot fall out. It has other restrictions on specific chemicals in rat poison because of adverse environmental impacts.
“EPA expects to see a substantial reduction in exposures to children when the 12 D-Con products that do not comply with current standards are removed from the consumer market as millions of households use these products each year,” the EPA said.
This isn’t the first spat between the regulator and Reckitt Benckiser. In 2010, the D.C. court of appeals ruled in favor of the U.K.-based company, saying the EPA violated the Federal Insecticide, Fungicide and Rodenticide Act, which allows the agency to set the levels and standards for the chemicals contained in pesticides and recall “misbranded” products.
In 2008, Reckitt Benckiser was the target of an EPA recall for 10 of its products, but the appeals court found the regulator did not give the company a notice or the chance for a hearing before it moved forward with the products' “cancellation.”








